Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs3136589 | chr3:172237826 | A/C | 8.63E-6 | 178 | 25.87 | 19.88 | 24.7 | KM Plot |
PCPG | rs3153 | chr21:34609505 | G/A | 0.000294 | 175 | 21.9 | 31.47 | 25.08 | KM Plot |
PCPG | rs3165 | chr21:38595912 | T/C | 0.000328 | 172 | 25 | 23.53 | 15.22 | KM Plot |
PCPG | rs3169375 | chr16:90110279 | C/T | 9.88E-9 | 175 | 25.77 | 20.2 | 6.62 | KM Plot |
PCPG | rs3178659 | chr16:1713758 | C/T | 5.01E-5 | 177 | 25.6 | 18.2 | 15.1 | KM Plot |
PCPG | rs3213892 | chr2:136552517 | G/A | 3.78E-5 | 173 | 25.77 | 20.2 | 9.72 | KM Plot |
PCPG | rs3215347 | chr12:53498783 | TA/T | 0 | 173 | 25.17 | 27.08 | 3.05 | KM Plot |
PCPG | rs329629 | chr17:3238989 | C/A | 0.000226 | 171 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs336564 | chr3:161075149 | G/A | 1.11E-16 | 173 | 25.87 | 19.85 | 1.63 | KM Plot |
PCPG | rs336571 | chr3:161068084 | C/T | 1.11E-16 | 174 | 25.87 | 19.85 | 1.63 | KM Plot |
PCPG | rs336573 | chr3:161067740 | A/G | 1.11E-16 | 174 | 25.87 | 19.85 | 1.63 | KM Plot |
PCPG | rs336576 | chr3:161066432 | C/G | 1.11E-16 | 174 | 25.87 | 19.85 | 1.63 | KM Plot |
PCPG | rs336581 | chr3:161082739 | T/C | 0.000268 | 172 | 25.87 | 19.85 | 3.17 | KM Plot |
PCPG | rs336584 | chr3:161081785 | C/A | 0.000236 | 174 | 25.87 | 19.85 | 3.17 | KM Plot |
PCPG | rs336588 | chr3:161080584 | G/T | 0.000236 | 174 | 25.87 | 19.85 | 3.17 | KM Plot |